Capital Contribution of KRW 15 Billion to Subsidiary for Liquidity
- Decided to contribute KRW 14,995 million (approx. KRW 15 billion) in cash to affiliate KOLON BIOTECH
- Purpose: to secure liquidity for the subsidiary; post-contribution, total investment in KOLON BIOTECH reaches KRW 70,892 million
- Expected contribution date: 2026.05.20, board resolution date: 2026.05.18 (1 outside director attended)
ADVERTISEMENT (250px+)
KOSDAQ Filing Information
- Filing: Investment in Related Parties
- Company: KOLON LIFE SCIENCE (102940)
- Submission: KOLON LIFE SCIENCE Inc.
- Receipt: 05-18-2026
- Under Fair Trade Commission (KFTC)